Biolegend, 640914, FITC Annexin V Apoptosis Detection Kit with PI
100tests
Catalog Number: 640914
Send an RFQ.
Category
| Verified Reactivity | Human, Mouse, Rat |
|---|---|
| Reported Reactivity | Other Species |
| Concentration | Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.) |
| Storage & Handling | Store between 2°C and 8°C. Do not freeze.Caution: Propidium Iodide Solution is toxigenic and mutagenic; handle with care. |
| Application | FC - Quality tested |
| Excitation Laser | Blue Laser (488 nm) |
| Application Notes | Annexin V Staining Wash cells twice with cold BioLegend Cell Staining Buffer (Cat. No. 420201) and then resuspend the desired amount of cells in Annexin V Binding Buffer (Cat. No. 422201) at a concentration of 0.25-1.0 x 107 cells/mL Transfer 100 µL of cell suspension in 5 mL test tube. Add 5 µL of fluorochrome conjugated Annexin V. Stain with a viability dye, such as PI (Cat. No. 421301), 7-AAD (Cat. Nos. 420403 & 420404), or Helix NP dyes (Cat. Nos. 425301, 425303, & 425305), if desired. Gently vortex the cells and incubate for 15 min at RT (25°C) in the dark. Add 400* µL of Annexin V Binding Buffer (Cat. No. 422201) to each tube. *For more concentrated samples, add a minimum of 200 µl of Annexin V Binding Buffer in this step. Analyze by flow cytometry. For a better experience detecting apoptosis, we now recommend Apotracker™. Cell staining with Apotracker™ is Calcium independent. Thus, no special buffers are required, and the protocol can be shortened for single-step co-staining with other reagents. |
Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:
Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.
| Application References(PubMed link indicates BioLegend citation) | Ranhanathan P, et al. 2013. J AM Soc Nephrol. PubMed Yu J, et al. 2014. PloS One. 9:114650. PubMed Wang Y, et al. 2014. Biochem Biophys Res Commun. 456:656. PubMed Jaishy B, et al. 2015. J Lipid Res. 56:546. PubMed |
|---|
| Product Citations | Ho J, et al. 2016. PLoS Biol. 14:e2000117. PubMed Markowicz-Piasecka M, et al. 2020. Apoptosis. 25:426. PubMed Lyu X, et al. 2019. Oncol Rep. 41:3137. PubMed Lanna A, et al. 2022. Nat Cell Biol. 24:1461. PubMed Parisay I, et al. 2022. Dent Res J (Isfahan). 19:79. PubMed Oh C, et al. 2022. Cell Rep. 41:111688. PubMed Kamalabadi-Farahani M, et al. 2023. Cancer Rep (Hoboken). 6:e1693. PubMed Tintelnot J, et al. 2023. Nature. 615:168. PubMed Du Y, et al. 2023. iScience. 26:106114. PubMed Chen S, et al. 2023. Exp Ther Med. 25:159. PubMed Tan Z, et al. 2023. Mol Cell Probes. 69:101913. PubMed Ceniti C, et al. 2023. Foods. 12:. PubMed Vokshi BH, et al. 2023. Nat Commun. 14:3034. PubMed Wang L, et al. 2023. Nat Commun. 14:3366. PubMed Rodina A, et al. 2023. Nat Commun. 14:3742. PubMed Su T, et al. 2021. Metabolites. 11:. PubMed Tiu GC, et al. 2021. Dev Cell. 56:2089. PubMed Li H, et al. 2022. Transfusion. 62:663. PubMed Rashed FB, et al. 2022. Redox Biol. 52:102300. PubMed Yang K, et al. 2022. Sci Immunol. 7:eabn2888. PubMed Zaarour RF, et al. 2022. Int J Mol Sci. 23: . PubMed Khan AN, et al. 2022. Molecules. 27: . PubMed Wei W, et al. 2022. Mol Med Rep. 26: . PubMed Li D, et al. 2022. Nucleic Acids Res. 50:12462. PubMed Park J, et al. 2022. Animals (Basel). 12: . PubMed Zhang H, et al. 2022. Exp Ther Med. 24:763. PubMed Bachmann LM, et al. 2023. Molecules. 28: . PubMed Song X, et al. 2022. Cancer Discov. 12:1294. PubMed Caballero M, et al. 2022. Front Mol Biosci. 9:752668. PubMed Zelenka T, et al. 2022. Nat Commun. 13:6954. PubMed Li MM, et al. 2018. Int J Infect Dis. 70:72. PubMed Fang H, et al. 2022. Exp Ther Med. 24:440. PubMed Chen J, et al. 2021. Antioxidants (Basel). 10:. PubMed Shimonosono M, et al. 2021. Biomolecules. 11:. PubMed Wang C, et al. 2021. Clin Transl Med. 11:e522. PubMed Yuan L, et al. 2015. Endocr Relat Cancer. 22: 577 - 591. PubMed Belo H, et al. 2015. PLoS One. 10: e0139740. PubMed Morita K, et al. 2020. Cell. 702:181. PubMed Yang J, et al. 2021. Oncoimmunology. 1875638:10. PubMed Guo Q, et al. 2018. Front Immunol. 9:1197. PubMed Soonthornchai W, et al. 2019. Asian Pac J Allergy Immunol. N/A. PubMed Son Y, et al. 2020. Mol Metab. 39:101005. PubMed Xie T, et al. 2021. Ann Transl Med. 9:1249. PubMed Kocak P, et al. 2021. Macromol Biosci. 21:e2000287. PubMed Li D, et al. 2022. Sci Adv. 8:eabm0478. PubMed Choromanska A, et al. 2020. Biomed Rep. 13:32. PubMed Mahmoud A, et al. 2016. Int J Toxicol. 35: 429 - 437. PubMed Liu J, et al. 2015. Biochem Biophys Res Commun. 463: Pags 262-267. PubMed Wang Y, et al. 2014. Biochem Biophys Res Commun. 456:656. PubMed Neumann CKA, et al. 2020. Mol Metab. 34:136. PubMed Ali DM, et al. 2019. Cell Death Discov. 5:128. PubMed Yao J, et al. 2018. Onco Targets Ther. 11:3793. PubMed Chang T, et al. 2016. Sci Rep. 6:23403. PubMed Shao M, et al. 2018. Evid Based Complement Alternat Med. 2018:6049498. PubMed Coelho CC, et al. 2019. Sci Rep. 9:11050. PubMed Orgaz JL, et al. 2020. Cancer Cell. 37:85. PubMed Vashist A, et al. 2022. Asian Pac J Cancer Prev. 23:3629. PubMed Korencak M, et al. 2019. JCI Insight. 4. PubMed Zhang W, et al. 2021. J Clin Invest. 131:. PubMed Kang DY, et al. 2022. J Oncol. 2022:6737248. PubMed Saboor-Maleki S, et al. 2016. Technol Cancer Res Treat. 10.1177/1533034616650119. PubMed Tatsuno K, et al. 2019. Cell Death Dis. 10:578. PubMed Ouyang J, et al. 2019. J Surg Res. 233:221. PubMed Xiao Y, et al. 2020. Nucleic Acids Res. 48:11113. PubMed Shen L, et al. 2021. Cell Death Discov. 7:392. PubMed Lian W, et al. 2022. J Immunol Res. 2022:3129765. PubMed Wu J, et al. 2020. Immunity. 53:115. PubMed Sareddy G, et al. 2016. Sci Rep. 6: 24185. PubMed Xie L, et al. 2020. Front Oncol. 1.354166667. PubMed Fei X, et al. 2019. Cancer Manag Res. 11:4781. PubMed Balachandran C, et al. 2017. Biomed Pharmacother. 10.1016/j.biopha.2017.06.096. PubMed Kiss E, et al. 2021. Int J Mol Sci. 22:. PubMed Cao W, et al. 2016. Nat Commun. 7:11687. PubMed Finetti F, et al. 2020. Cell Death Differ. 27:310. PubMed Xing W, et al. 2020. J Recept Signal Transduct Res. 1:. PubMed Virumbrales–Muñ oz M, et al. 2019. Sci Rep. 9:6199. PubMed Allur Subramaniyan S, et al. 2018. Cell Commun Adhes. 24:19. PubMed Chen J, et al. 2021. J Oncol. 2021:5572402. PubMed Liu R, et al. 2021. Oncol Lett. 21:06. PubMed Perez E, et al. 2020. J Immunol. 205:2489. PubMed Callender LA, et al. 2021. Nat Commun. 12:3379. PubMed Blue E, et al. 2015. Diabetes. 64: 2664 - 2675. PubMed Kongkavitoon P, et al. 2016. PLoS One. 11: 0146696. PubMed Coden ME, et al. 2020. J Immunol. 204:438. PubMed Sohrabi Y, et al. 2019. Front Immunol. 9:3155. PubMed Changizi V, et al. 2021. Iran J Med Sci. 46:291. PubMed Zhang N, et al. 2021. Atherosclerosis. 334:39. PubMed Hu K, et al. 2020. Nat Commun. 2778:11. PubMed Jaishy B, et al. 2015. J Lipid Res. 56:546. PubMed Shin JJ, et al. 2020. Cell Rep. 32:108093. PubMed Soonthornchai W, et al. 2021. Sci Rep. 11:14186. PubMed Still C 2nd, et al. 2021. Cell Reports Medicine. 2(7):100343. PubMed Tailor D, et al. 2020. Br J Cancer. . PubMed Ryva B, et al. 2019. Front Oncol. 9:100. PubMed Flegkas A, et al. 2019. Medicines (Basel). 6:1. PubMed Wu A, et al. 2020. Cell Death Dis. 11:40. PubMed Patil M, et al. 2021. Circ Res. 129:1006. PubMed Abokyi S, et al. 2021. Int J Mol Sci. 22:. PubMed Huang S, et al. 2022. J Cancer. 13:2662. PubMed Merikhian P, et al. 2022. Mol Oncol. 16:485. PubMed Zhou Y, et al. 2021. NPJ Regen Med. 6:34. PubMed Ma H, et al. 2015. Sci Rep. 5: 15121. PubMed Kan L, et al. 2015. PLoS One. 10: 0144513. PubMed Wang YL, et al. 2021. Environ Health Perspect. 129:57003. PubMed Zhou L, et al. 2021. Front Oncol. 11:668617. PubMed Dudek M, et al. 2021. Nature. 592:444. PubMed Rodriguez E, et al. 2021. Cancers (Basel). 13:. PubMed Zhou Q, et al. 2020. J Invest Dermatol. . PubMed Chou ST, et al. 2020. Chin Med. 0.678472222. PubMed Weiss R, et al. 2015. Innate Immunity. 21: 813 - 826. PubMed Yu J, et al. 2014. PLoS One. 9:114650. PubMed Viereckl MJ, et al. 2022. Biomolecules. 12:. PubMed Roupakia E, et al. 2021. Cancers (Basel). 13:. PubMed Pires D, et al. 2021. Front Immunol. 12:647728. PubMed Lonardi S, et al. 2020. Cancer Immunol Res. 829:8. PubMed Cho S, et al. 2019. Transl Oncol. 0.820138889. PubMed Wang JS, et al. 2021. Nat Commun. 12:6271. PubMed Li XR, et al. 2020. Neoplasma. 67:982. PubMed Zakharova I, et al. 2022. Front Bioeng Biotechnol. 10:772981. PubMed Yang Y, et al. 2022. Int J Mol Sci. 23:. PubMed Choromanska A, et al. 2020. Pharmaceutics. 12:00. PubMed Levy G, et al. 2015. PLoS One. 10: 0136070. PubMed Zamani K, et al. 2021. BMC Biotechnol. 21:68. PubMed Biadglegne F, et al. 2021. Mol Med Rep. 24:. PubMed Li C, et al. 2018. Cell Physiol Biochem. 45:366. PubMed Wang X, et al. 2020. Onco Targets Ther. 13:1691. PubMed Wang N, et al. 2020. Front Immunol. 1.765972222. PubMed Zhong X, et al. 2021. Oncol Lett. 245:21. PubMed Wang W, et al. 2020. Cancer Cell Int. 1.06875. PubMed Lin B, et al. 2020. Mol Med Rep. 21:2171. PubMed Zheng M, et al. 2019. Proc Natl Acad Sci U S A. 116:12422. PubMed Lauko A, et al. 2022. Cell Rep. 40:111348. PubMed |
|---|
| Biology Area | Apoptosis/Tumor Suppressors/Cell Death, Cell Biology, Neuroscience |
|---|
| Gene ID | 308 |
|---|
| Regulatory Status | RUO |
|---|
| Other Names | Annexin A5 Apoptosis Detection Kit, Dead, Apoptosis |
|---|